Jack Feehan

Dr. Jack Feehan is a Vice Chancellor’s Senior Research Fellow in the School of Health and Biomedical Sciences at RMIT University. His research focuses on immunology, aging-related health, cancer biology, and vaccine development. He leads projects addressing colorectal cancer drug targeting, digital capacity in aged care, and vitamin therapies for cancer and diabetes. Dr. Feehan is affiliated with RMIT’s Health Innovations Research Institute and collaborates with institutions like the University of Technology Sydney and the Australian Research Consortium in Complementary and Integrative Medicine.

• Education background not explicitly stated but implies advanced training in biomedical sciences
• Current roles include advisory committee membership for Osteopathy Australia and research leadership fellowships

Key research interests span inflammation’s role in disease, musculoskeletal health in aging populations, and translational vaccine development. His clinical trials investigate carnosine supplementation effects on diabetes outcomes and mental health. Dr. Feehan’s work aligns with UN Sustainable Development Goals 3 (Health) and 17 (Partnerships).

Recent publications emphasize emerging viral threats (oropouche fever, mpox), cannabinoid impacts on male reproduction, and osteopathic research capacity building. He supervises 12 active research projects exploring topics like predictive safety modeling and interprofessional allied health collaboration in falls prevention.